RefinedPractice
An Insurance Framework for Funding New Antibiotics
22 September 2017
A new paper sets out an insurance model as part of a global solution to incentivise R&D for new antibiotics to tackle multi-drug resistance. It offers…
What Determines Health Care Expenditure in High Income Countries?
18 September 2017
OHE’s Yan Feng and Grace Hampson, along with colleagues from the Health Foundation and RAND Europe, have published a new paper in Applied Economics and Finance…
OHE Lunchtime Seminar: NHS Agency Staffing and the Impact of Recent Interventions
6 September 2017
On Friday 6th October 2017, Chris Mullin, Chief Economist at the Department of Health, will lead an OHE Lunchtime Seminar on the topic of: NHS agency…
A New Valuation Method: Directly Eliciting Personal Utility Functions
30 August 2017
A new OHE Research Paper describes a novel approach for valuing health-related quality of life: directly eliciting personal utility functions
An Update on the EQ-5D-5L Value Set for England
22 August 2017
In this blog we (1) summarise the current status of the EQ-5D-5L value set for England; (2) highlight NICE’s recent statement on the values to be…
Comparing the EQ-5D-3L and EQ-5D-5L in a Cohort of Cancer Patients: A Research Collaboration between OHE, Curtin University and King’s College London
15 August 2017
OHE, Curtin and KCL have been awarded a research grant from the EuroQol Research Foundation to compare the EQ-5D-3L and EQ-5D-5L instruments in cancer patients.
New OHE Seminar Briefing: Interventions that Encourage High-value Nursing Home Care: Lessons for the UK
11 August 2017
This OHE Seminar Briefing summarises a seminar given by Professor David Grabowski, which provided a health economics perspective on how payment and delivery interventions can encourage…
OHE at iHEA 2017: Presentations
8 August 2017
The presentations delivered by OHE at the iHEA congress, July 2017, are available in this post.
OHE Lunchtime Seminar: How Cost-Effective are New Cancer Drugs in the U.S.?
2 August 2017
On Tuesday 19th September 2017, Professor Frank Lichtenberg from Columbia University will lead an OHE Lunchtime Seminar on the topic of: How cost-effective are new cancer…